Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Integrated Diagnostics Holdings ( (GB:IDHC) ) just unveiled an update.
Integrated Diagnostics Holdings reported strong first-quarter 2026 results, with revenue rising 31% year on year to EGP 2.1 billion, driven by a 22% increase in test volumes and higher revenue per test. The group expanded its network to 794 branches and served 2.2 million patients, with Egypt remaining the main growth engine alongside contributions from Jordan, Nigeria and Saudi Arabia.
Profitability remained robust despite the seasonal drag from Ramadan and Eid and pre-operating costs for a new Al Borg Scan branch, as gross profit climbed 28% and EBITDA 23% while adjusted net profit increased 36%. Management highlighted efficiencies from procurement, disciplined cost control and digitalisation, with higher radiology and specialised diagnostics usage supporting pricing and margins, underpinned by a growing cash position and continued regional expansion.
More about Integrated Diagnostics Holdings
Integrated Diagnostics Holdings is a leading diagnostics services provider operating across Egypt, Jordan, Nigeria, Saudi Arabia and Sudan, offering laboratory tests, radiology and specialised diagnostics. The group focuses on expanding its branch network and enhancing service mix to capture growing demand for healthcare diagnostics in its core emerging markets.
Average Trading Volume: 167,850
Technical Sentiment Signal: Buy
Current Market Cap: $325.5M
For an in-depth examination of IDHC stock, go to TipRanks’ Overview page.